Description

MAGRAL 160 is a pharmaceutical medication containing the active ingredient megestrol acetate 160 mg. This drug is primarily used for its powerful effects in stimulating appetite and promoting weight gain, especially in patients experiencing severe weight loss due to chronic illnesses. It belongs to the class of progestins, synthetic derivatives of the female hormone progesterone, which exert multiple biological effects. Megestrol tablets are used to treat advanced uterine or breast cancer in individuals whose disease has returned, spread, or is not amenable to surgical treatment. MAGRAL 160 is also recognized for its antineoplastic properties, meaning it helps in the treatment of certain cancers. This dual action makes the medication valuable in managing complex conditions involving both anorexia and malignancies. Its formulation and dosage are designed for effective therapeutic outcomes under medical supervision. What is MAGRAL 160? MAGRAL 160 contains megestrol acetate 160 mg, a synthetic progestogen with properties that increase appetite and induce weight gain. It is used medically to counteract significant weight loss and loss of appetite seen in patients suffering from chronic diseases like cancer or AIDS. Additionally, it functions as an antineoplastic agent, helping to manage hormone-responsive cancers by influencing hormone activity and tumor growth. Uses of MAGRAL 160 To treat anorexia (loss of appetite), cachexia (muscle wasting), or serious unexplained weight loss commonly observed in patients with chronic diseases such as cancer or acquired immunodeficiency syndrome (AIDS). As an antineoplastic agent, it is used to treat certain types of malignancies such as advanced breast cancer and endometrial cancer, especially those that are hormone dependent. In palliative care to improve quality of life by enhancing nutritional intake and weight stabilization. Occasionally prescribed off-label for other hormone-responsive conditions under medical guidance. Side Effects of MAGRAL 160 Weight gain (often desired in treated conditions but should be monitored). Edema (swelling due to fluid retention). Nausea and vomiting. Vaginal bleeding irregularities in women. Gastrointestinal disturbances such as constipation or diarrhea. Fatigue, weakness, and insomnia. Headache, dizziness, and mood changes. Potential glucocorticoid-like effects including symptoms resembling Cushing’s syndrome in rare cases. Increased risk of blood clots, which requires careful monitoring. Precautions Before Using MAGRAL 160 Inform your doctor if you have a history of blood clots, cardiovascular disease, liver or kidney issues, diabetes, or hormone-sensitive cancers. Disclose any current medications or supplements to avoid potential interactions. Not recommended during pregnancy or breastfeeding due to hormone-related effects. Regular monitoring of blood sugar, hormone levels, and overall health is essential during treatment. Avoid abrupt discontinuation; dosage adjustments should always be done under medical supervision. Drug Interactions: What Drugs Interact with MAGRAL 160? Co-administration with corticosteroids or drugs with glucocorticoid activity may amplify certain side effects. Drugs that affect liver enzymes (such as CYP3A4 inhibitors or inducers) can potentially alter the metabolism of megestrol acetate, affecting its efficacy and safety. Concurrent use with anticoagulants requires caution due to altered clotting risk. Hormonal therapies or contraceptives might interact through hormonal pathways, modifying therapeutic outcomes. Conclusion: MAGRAL 160 with its active ingredient megestrol acetate 160 mg is a specialized medication designed to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy. Its effective use demands careful consideration of benefits versus risks, adherence to prescribed dosage, awareness of side effects, and thorough communication with healthcare providers for safe and optimal results.